SnO2-xNx based tpod nanostructure for SARS-CoV2 spike protein detection

Environ Res. 2023 Oct 1:234:116505. doi: 10.1016/j.envres.2023.116505. Epub 2023 Jul 3.

Abstract

The worldwide spreading of severe acute respiratory syndrome SARS-CoV2 pandemic, a massive setback to every human being. In response to strategies actions against Covid-19 spreading many detection, prevention, and post-measures are being studied in large capacities. Association of SARS-CoV2 with ACE2 is well acknowledged and used for developing point-of-care detection kits. Recently, cases and studies have surfaced showing relation of ACE I/D polymorphism with spreading of SARS-CoV2 and highlighted a slip section towards detection and these studies show specificity with older males, high diabetes, and hypertension. To address the raised concern, we report synthesis of unique SnO2-xNx tpod nanostructure, showing affirmative attachment to both ACE1 and ACE2 efficiently. The attachment is examined in different ratios and studied with μ-Raman spectroscopy. The tpod nanostructure has served with its signature raman signals and used as probe for detection of SARS-CoV2 spike protein (S1). The linearity response for tpod raman signal at 630.4 cm-1 shows R2 0.9705, comparatively peak 1219.13 cm-1 show R2 0.9865 and calculated limit of detection of 35 nM.

Keywords: Angiotensin converting enzyme (ACE); RAAS; SARS-CoV2; SnO2-xNx; Tpod nanostructure.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiotensin-Converting Enzyme 2
  • COVID-19*
  • Humans
  • Male
  • Peptidyl-Dipeptidase A
  • RNA, Viral
  • SARS-CoV-2 / genetics
  • Spike Glycoprotein, Coronavirus / genetics

Substances

  • RNA, Viral
  • Peptidyl-Dipeptidase A
  • Angiotensin-Converting Enzyme 2
  • spike protein, SARS-CoV-2
  • Spike Glycoprotein, Coronavirus